Table 4 Adverse events
|  | EUS-FNA (N = 160) | ERCP (N = 88) | p value |
|---|---|---|---|
Adverse events, n (%) | 2 (1.3) | 9 (10.2) | 0.001 |
 Mild pancreatitis | 0 | 5 |  |
 Bleeding | 1 | 3 |  |
 Bile duct perforation | 0 | 1 |  |
 Abdominal pain | 1 | 0 |  |
|  | EUS-FNA (N = 160) | ERCP (N = 88) | p value |
|---|---|---|---|
Adverse events, n (%) | 2 (1.3) | 9 (10.2) | 0.001 |
 Mild pancreatitis | 0 | 5 |  |
 Bleeding | 1 | 3 |  |
 Bile duct perforation | 0 | 1 |  |
 Abdominal pain | 1 | 0 |  |